» Articles » PMID: 37660060

Integrated Machine Learning Survival Framework Develops a Prognostic Model Based on Inter-crosstalk Definition of Mitochondrial Function and Cell Death Patterns in a Large Multicenter Cohort for Lower-grade Glioma

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Sep 2
PMID 37660060
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lower-grade glioma (LGG) is a highly heterogeneous disease that presents challenges in accurately predicting patient prognosis. Mitochondria play a central role in the energy metabolism of eukaryotic cells and can influence cell death mechanisms, which are critical in tumorigenesis and progression. However, the prognostic significance of the interplay between mitochondrial function and cell death in LGG requires further investigation.

Methods: We employed a robust computational framework to investigate the relationship between mitochondrial function and 18 cell death patterns in a cohort of 1467 LGG patients from six multicenter cohorts worldwide. A total of 10 commonly used machine learning algorithms were collected and subsequently combined into 101 unique combinations. Ultimately, we devised the mitochondria-associated programmed cell death index (mtPCDI) using machine learning models that exhibited optimal performance.

Results: The mtPCDI, generated by combining 18 highly influential genes, demonstrated strong predictive performance for prognosis in LGG patients. Biologically, mtPCDI exhibited a significant correlation with immune and metabolic signatures. The high mtPCDI group exhibited enriched metabolic pathways and a heightened immune activity profile. Of particular importance, our mtPCDI maintains its status as the most potent prognostic indicator even following adjustment for potential confounding factors, surpassing established clinical models in predictive strength.

Conclusion: Our utilization of a robust machine learning framework highlights the significant potential of mtPCDI in providing personalized risk assessment and tailored recommendations for metabolic and immunotherapy interventions for individuals diagnosed with LGG. Of particular significance, the signature features highly influential genes that present further prospects for future investigations into the role of PCD within mitochondrial function.

Citing Articles

Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors.

Lin Y, Li H, Ge Q, Hua D Transl Cancer Res. 2025; 14(1):240-253.

PMID: 39974385 PMC: 11833365. DOI: 10.21037/tcr-24-1035.


Single-cell programmed cell death regulator patterns guide intercellular communication of cancer-associated fibroblasts that contribute to colorectal cancer progression.

Yao K, Zhang S, Zhu B, Sun Y, Tian K, Yan Y Transl Cancer Res. 2025; 14(1):434-460.

PMID: 39974383 PMC: 11833379. DOI: 10.21037/tcr-24-1301.


Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and / experiments.

Yin B, Ren J, Liu X, Zhang Y, Zuo J, Wen R Front Pharmacol. 2025; 16:1524448.

PMID: 39906141 PMC: 11790656. DOI: 10.3389/fphar.2025.1524448.


A Journey into the Complexity of Temporo-Insular Gliomas: Case Report and Literature Review.

Encarnacion Ramirez M, Reyes Soto G, Castillo Rangel C Curr Oncol. 2025; 32(1.

PMID: 39851957 PMC: 11764291. DOI: 10.3390/curroncol32010041.


Integration of machine learning and experimental validation to identify the prognostic signature related to diverse programmed cell deaths in breast cancer.

Li L, Zhao J, Wang Y, Zhang Z, Chen W, Wang J Front Oncol. 2025; 14():1505934.

PMID: 39834939 PMC: 11744720. DOI: 10.3389/fonc.2024.1505934.


References
1.
Gusyatiner O, Hegi M . Glioma epigenetics: From subclassification to novel treatment options. Semin Cancer Biol. 2017; 51:50-58. DOI: 10.1016/j.semcancer.2017.11.010. View

2.
Schiff D, van den Bent M, Vogelbaum M, Wick W, Miller C, Taphoorn M . Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus. Neuro Oncol. 2019; 21(7):837-853. PMC: 6620638. DOI: 10.1093/neuonc/noz033. View

3.
Nabors L, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S . Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020; 18(11):1537-1570. DOI: 10.6004/jnccn.2020.0052. View

4.
Traunwieser T, Kandels D, Pauls F, Pietsch T, Warmuth-Metz M, Bison B . Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies. Neurooncol Adv. 2020; 2(1):vdaa094. PMC: 7497816. DOI: 10.1093/noajnl/vdaa094. View

5.
LaPointe S, Perry A, Butowski N . Primary brain tumours in adults. Lancet. 2018; 392(10145):432-446. DOI: 10.1016/S0140-6736(18)30990-5. View